Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Saudubray

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
European Journal of Clinical Pharmacology|January 1, 1992
Azelastine reduces allergen-induced nasal response: a clinical and rhinomanometric assessmentA Lurie, F Saudubray, J L Eychenne, et al.
Journal of Pain and Symptom Management|October 1, 1992
A comparative study of controlled-release morphine (CRM) suspension and CRM tablets in chronic cancer painF Boureau, F Saudubray, C d'Arnoux, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|June 26, 2003
Characteristics of EPI-hNE4 aerosol: a new elastase inhibitor for treatment of cystic fibrosisD Grimbert, L Vecellio, P Delépine, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
European Journal of Clinical Pharmacology|January 1, 1992
Azelastine reduces allergen-induced nasal response: a clinical and rhinomanometric assessmentA Lurie, F Saudubray, J L Eychenne, et al.
Journal of Pain and Symptom Management|October 1, 1992
A comparative study of controlled-release morphine (CRM) suspension and CRM tablets in chronic cancer painF Boureau, F Saudubray, C d'Arnoux, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|June 26, 2003
Characteristics of EPI-hNE4 aerosol: a new elastase inhibitor for treatment of cystic fibrosisD Grimbert, L Vecellio, P Delépine, et al.
Pageof 2